Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or "the Company") today announced that William (Bill) Garriock has resigned from his position of Chair of Cipher, effective December 31, 2013, as...

Revenue increases to $5.6 million and earnings per share rise to $0.14 Toronto Stock Exchange Symbol: DND MISSISSAUGA,, ON, Oct. 30, 2013 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher")...

Cipher Pharmaceuticals Inc. (TSX: DND) (OTC: CPHMF), today announced it will host a conference call for its Q3 2013 financial results on Wednesday, October 30, 2013. Q3 2013 CONFERENCE CALL WHEN:...

Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher") today announced that its sales and distribution partner, Ranbaxy Laboratories Inc. ("Ranbaxy") has received a Paragraph IV Certification Notice of...

Revenue increases to $5.5 million; Company records earnings per share of $0.13 Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, July 31, 2013 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND)...

Cipher Pharmaceuticals Inc. (TSX: DND) (OTC: CPHMF), today announced it will host a conference call for its Q2 2013 financial results on Wednesday, July 31, 2013. Q2 2013 CONFERENCE CALL WHEN:...

At the 88th annual Canadian Dermatology Association Conference held in Quebec City over the July 1st weekend, Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher") announced the Canadian launch of...

- Revenue increases 82%, Company records earnings of $0.06 per share - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, May 3, 2013 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND); (OTC: CPHMF)...

Cipher Pharmaceuticals Inc. (TSX: DND; OTC: CPHMF) today announced it has entered into a definitive distribution and supply agreement with Tecnofarma International Ltd. ("Tecnofarma") under which...

Cipher Pharmaceuticals Inc. (TSX: DND; OTC: CPHMF) today announced it will host a conference call for its Q1 2013 financial results and hold its Annual and Special Meeting of Shareholders on...